D.E. Shaw & Co’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $228M | Buy |
|
|||||
|
2021
Q1 | $165M | Buy |
|
|||||
|
2020
Q4 | $130M | Buy |
|
|||||
|
2020
Q3 | $88.6M | Buy |
|
|||||
|
2020
Q2 | $35.5M | Sell |
|
|||||
|
2020
Q1 | $66.1M | Sell |
|
|||||
|
2019
Q4 | $95.6M | Sell |
|
|||||
|
2019
Q3 | $160M | Buy |
|
|||||
|
2019
Q2 | $34.6M | Buy |
|
|||||
|
2019
Q1 | $22M | Sell |
|
|||||
|
2018
Q4 | $83.2M | Buy |
|
|||||
|
2018
Q3 | $72.8M | Sell |
|
|||||
|
2018
Q2 | $73.5M | Sell |
|
|||||
|
2018
Q1 | $72.5M | Buy |
|
|||||
|
2017
Q4 | $42M | Buy |
|
|||||
|
2017
Q3 | $16.2M | Sell |
|
|||||
|
2017
Q2 | $35.2M | Buy |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $5.04M | Sell |
|
|||||
|
2016
Q2 | $22.4M | Sell |
|
|||||
|
2016
Q1 | $27.8M | Sell |
|
|||||
|
2015
Q4 | $68.3M | Sell |
|
|||||
|
2015
Q3 | $76.4M | Buy |
|
|||||
|
2015
Q2 | $59M | Buy |
|
|||||
|
2015
Q1 | $3.75M | Sell |
|
|||||
|
2014
Q4 | $29.1M | Buy |
|
|||||
|
2014
Q3 | $10.1M | Sell |
|
|||||
|
2014
Q2 | $27.2M | Sell |
|
|||||
|
2014
Q1 | $30.8M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $9.72M | Sell |
|
|||||
|
2013
Q2 | $11.7M | Buy |
|